InhibRx's Unattributed Round

InhibRx raised a round of funding on May 10, 2018.

InhibRx is a biologic immunotherapeutic company focused on the treatment of unmet medical needs. Inhibrx's proprietary platforms enable fit-for-function biotherapeutics that optimally interface with t…

Articles about InhibRx's Unattributed Round: